Letters to the Editor

nork Shellito, Paul C.
Argitaratua 2000

Wound Dehiscence After APR for Low Rectal Cancer is Associated with Decreased Survival

nork Hawkins, Alexander T., Berger, David L., Shellito, Paul C., Sylla, Patrica, Bordeianou, Liliana
Argitaratua 2014

Long-Term Follow-Up of Patients With Rectal Cancer Managed by Local Excision With and Without Adjuvant Irradiation

nork Chakravarti, Arnab, Compton, Carolyn C., Shellito, Paul C., Wood, William C., Landry, Jerome, Machuta, Shelley R., Kaufman, Donald, Ancukiewicz, Marek, Willett, Christopher G.
Argitaratua 1999

Early stage rectal cancer: clinical and pathologic prognostic markers of time to local recurrence and overall survival after resection

nork Patel, Sagar A., Chen, Yu-Hui, Hornick, Jason L., Catalano, Paul, Nowak, Jonathan A., Zukerberg, Lawrence R., Bleday, Ronald, Shellito, Paul C., Hong, Theodore S., Mamon, Harvey J.
Argitaratua 2014

Plasma Soluble VEGFR-1 Is a Potential Dual Biomarker of Response and Toxicity for Bevacizumab with Chemoradiation in Locally Advanced Rectal Cancer

nork Duda, Dan G., Willett, Christopher G., Ancukiewicz, Marek, di Tomaso, Emmanuelle, Shah, Mira, Czito, Brian G., Bentley, Rex, Poleski, Martin, Lauwers, Gregory Y., Carroll, Madeline, Tyler, Douglas, Mantyh, Christopher, Shellito, Paul, Clark, Jeffrey W., Jain, Rakesh K.
Argitaratua 2010

Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1α, CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer

nork Xu, Lei, Duda, Dan G., di Tomaso, Emmanuelle, Ancukiewicz, Marek, Chung, Daniel C., Lauwers, Gregory Y., Samuel, Rekha, Shellito, Paul, Czito, Brian G., Lin, Pei-Chun, Poleski, Martin, Bentley, Rex, Clark, Jeffrey W., Willett, Christopher G., Jain, Rakesh K.
Argitaratua 2009

A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer

nork Willett, Christopher G., Duda, Dan G., Ancukiewicz, Marek, Shah, Mira, Czito, Brian G., Bentley, Rex, Poleski, Martin, Fujita, Hiroshi, Lauwers, Gregory Y., Carroll, Madeline, Tyler, Douglas, Mantyh, Christopher, Shellito, Paul, Chung, Daniel C., Clark, Jeffrey W., Jain, Rakesh K.
Argitaratua 2010

Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study

nork Willett, Christopher G., Duda, Dan G., di Tomaso, Emmanuelle, Boucher, Yves, Ancukiewicz, Marek, Sahani, Dushyant V., Lahdenranta, Johanna, Chung, Daniel C., Fischman, Alan J., Lauwers, Gregory Y., Shellito, Paul, Czito, Brian G., Wong, Terence Z., Paulson, Erik, Poleski, Martin, Vujaskovic, Zeljko, Bentley, Rex, Chen, Helen X., Clark, Jeffrey W., Jain, Rakesh K.
Argitaratua 2009

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

nork Willett, Christopher G, Boucher, Yves, di Tomaso, Emmanuelle, Duda, Dan G, Munn, Lance L, Tong, Ricky T, Chung, Daniel C, Sahani, Dushyant V, Kalva, Sanjeeva P, Kozin, Sergey V, Mino, Mari, Cohen, Kenneth S, Scadden, David T, Hartford, Alan C, Fischman, Alan J, Clark, Jeffrey W, Ryan, David P, Zhu, Andrew X, Blaszkowsky, Lawrence S, Chen, Helen X, Shellito, Paul C, Lauwers, Gregory Y, Jain, Rakesh K
Argitaratua 2004